A clinical trial of adjunctive estrogen treatment in women with chronic schizophrenia: A double blind and placebo controlled study

被引:0
|
作者
Akhondzadeh, S
Nejatisafa, AA
Amini, H
机构
[1] Univ Tehran Med Sci, Roozbeh Psychiat Hosp, Tehran, Iran
[2] Inst Med Plants, Tehran, Iran
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
21P
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial
    Akhondzadeh, S
    Nejatisafa, AA
    Amini, H
    Mohammadi, MR
    Larijani, B
    Kashani, L
    Raisi, F
    Kamalipour, A
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (06): : 1007 - 1012
  • [2] A clinical trial of adjunctive celecoxib treatment in patients with chronic schizophrenia: a double-blind and placebo controlled trial
    Akhondzadeh, S.
    Tabatabaee, M.
    Amini, H.
    Ahmadi-Abhari, S. A.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (06) : 774 - 774
  • [3] Combination of estrogen and antipsychotics in the treatment of women with chronic schizophrenia: A double-blind, randomized, and placebo-controlled trial
    Mohammadi, A.
    Ghafari, E.
    Kheramine, S.
    Shirazi, H. Ghaffarian
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 229 - 229
  • [4] Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial
    Usall, Judith
    Huerta-Ramos, Elena
    Iniesta, Raquel
    Cobo, Jesus
    Araya, Susana
    Roca, Mercedes
    Serrano-Blanco, Antoni
    Teba, Fernando
    Ochoa, Susana
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (11) : 1552 - 1557
  • [5] Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial
    Mozen-Zadeh, Ehsan
    Bayanati, Samaneh
    Ziafat, Kimia
    Rezaei, Farzin
    Mesgarpour, Bita
    Akhondzadeh, Shahin
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2020, 34 (05) : 506 - 513
  • [6] A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia
    Friedman, JI
    Adler, DN
    Howanitz, E
    Harvey, PD
    Brenner, G
    Temporini, H
    White, L
    Parrella, M
    Davis, KL
    [J]. BIOLOGICAL PSYCHIATRY, 2002, 51 (05) : 349 - 357
  • [7] A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia
    Friedman, JI
    Adler, DN
    Howanitz, E
    Harvey, PD
    Brenner, G
    Temporini, H
    White, L
    Parrella, M
    Davis, KL
    [J]. SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 9 - 9
  • [8] Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial
    Abdallah, Mahmoud S.
    Mosalam, Esraa M.
    Hassan, Ahmed
    Ramadan, Ahmed N.
    Omara-Reda, Hend
    Zidan, Abdel-Aziz A.
    Samman, Waad A.
    El-Berri, Eman, I
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (01) : 354 - 364
  • [9] Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study
    Zhu, Weiwei
    Zhang, Zhanchou
    Qi, Jingfeng
    Liu, Fang
    Chen, Jindong
    Zhao, Jingping
    Guo, Xiaofeng
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 1317 - 1323
  • [10] Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial
    Gilda Kianimehr
    Farzad Fatehi
    Sara Hashempoor
    Mohammad-Reza Khodaei-Ardakani
    Farzin Rezaei
    Ali Nazari
    Ladan Kashani
    Shahin Akhondzadeh
    [J]. DARU Journal of Pharmaceutical Sciences, 22